Hematology & Oncology Doctors in Marshfield, WI Accepting Medicare

8 Hematology & Oncology doctors found. Showing 1 - 8

Isaac Yeboah, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-221-5257

Seth Fagbemi, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5426

Lawrence H Clouse, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5425

Tarit K Banerjee, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5134

William G. Hocking, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5426

Chady Abboud Leon, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511

Dr. Joseph Edmund, M.B.B.S Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511

Moira M. Lancelot, Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511

News Archive

Solbec announces pre-clinical study to confirm findings into the effect of Coramsine combined with CpG in the treatment of murine mesothelioma

Solbec Pharmaceuticals Ltd has announced the commencement of a pre-clinical study to confirm and extend the findings of an earlier investigation into the effect of Coramsine™ combined with CpG in the treatment of murine mesothelioma.

Governors feeling the pinch on Medicaid funding

Medicaid was created in 1965 to provide health coverage for the poorest Americans, particularly those with children. States pay, on average, 43% of the tab for Medicaid. Washington pays the rest and, as part of the new health-care law, the federal government restricts states' ability to save money by narrowing eligibility for the program or charging more for coverage.

Burden of funding, driving research on rare diseases too often falls upon patients, families: NORD

An advocate for people with rare diseases today told a U.S. Senate committee that the burden of funding and driving research on rare diseases too often falls upon patients and their families.

Growing acceptance of medical grade displays drives global growth

While the lasting effects of the economic recession will restrict the market in the short-term, growth in the world market for medical grade displays is forecast to accelerate from 2012 as the global economy improves and previously postponed hospital projects are initiated.

Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer

Pre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major pathological responses in 100% of early-stage colon cancers with mismatch repair deficiencies, according to results reported at ESMO 2018 from the first exploratory phase II trial to investigate this approach.

Read more Medical News

› Verified 8 days ago